The authors introduce multistate enzyme design: multiple DFT-derived theozymes (TS1-TS4 of the four-step Morita-Baylis-Hillman mechanism) are independently placed onto members of a phenix.ensemble_refinement backbone ensemble of BH32.12, then sequences are optimized in Triad with a fitness function penalizing destabilization of any state. This is a logical extension of their prior ensemble-based design work on Kemp eliminases . The headline result: BH32.M6 achieves 440 M⁻²s⁻¹ bi-substrate efficiency vs 4 for single-state BH32.S8 and 210 for evolved BH32.12, with 93% ee(R) .
The paper does not rely on activity alone. KIE experiments show BH32.M6 retains rate-limiting proton transfer at TS3, while BH32.S8 loses the KIE; KSVE slopes (<0.5 for S8, >0.5 for M6/BH32.12) and a 4-fold higher kinact for M6 jointly support the interpretation that single-state design relocated the bottleneck to an upstream step. Crystallography corroborates: BH32.M6 samples productive His23 rotamers in 77% of ensemble structures vs 24% for S8, and shows lower modal Arg124 RMSDs for three of four transition states than all variants including BH32.12. This multi-pronged mechanistic triangulation (kinetics, KIE/KSVE, structures, RAMD) is well above the standard for enzyme design papers.
1. kcat of BH32.M6 (0.031 min⁻¹) is actually ~2-fold lower than BH32.12 (0.058) β the efficiency gain over directed evolution comes entirely from a 5-fold lower KM,2CH (0.84 vs 4.3 mM). The claim of "surpassing" directed evolution is thus efficiency-specific, not turnover-specific, and deserves clearer framing than the abstract provides.
2. Confounded comparison. Multistate variants carry 8-10 mutations vs 12-13 for single-state designs; only 10 designs per strategy were tested from 1,000 candidates, with different filtering criteria (the energy-variation filter was only applicable to multistate designs). Only one single-state target (TS3) was compared, not TS1 or TS2, so the generality of the "single-state design creates bottlenecks" claim rests on n=1 target.
3. Single-scaffold demonstration. Everything is on the BH32.12 scaffold and one reaction; the retro-aldol precedent showed design outcomes vary wildly across scaffolds . The authors acknowledge this and propose combining with generative backbones, but that remains untested.
4. LigandMPNN comparison is potentially unfair. The homotetramer trick feeding four theozyme structures to LigandMPNN is an ad-hoc adaptation; no energetic balancing term exists in the model, and no fine-tuning or alternative implementations (e.g., different temperatures, multi-state losses) were explored. The conclusion "deep learning yields limited gains" may reflect implementation, not a fundamental limit.
5. No explicit limitations section; BH32.S8 enantioselectivity is reported as N.D. due to aldol by-product interference β an honest disclosure, but it removes the stereoselectivity comparison for the key single-state control.
A well-controlled, mechanistically rigorous methods advance that provides the first direct experimental test of multistate vs single-state sequence optimization on identical scaffolds and sequence space. Confidence in the BH32-specific conclusion is high (moderate-strength evidence from n=2-8 protein batches per variant, three protein batches for KIE/KSVE); confidence in generalizability is lower pending replication on other scaffolds and reactions . Falsification would require showing a TS3-targeted single-state design matching BH32.M6 efficiency while retaining TS3 rate limitation.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.